Barclays PLC Orasure Technologies Inc Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

A detailed history of Barclays PLC transactions in Orasure Technologies Inc stock. As of the latest transaction made, Barclays PLC holds 195,793 shares of OSUR stock, worth $712,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares
195,793
Previous 195,793 -0.0%
Holding current value
$712,686
Previous $836,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$3.93 - $4.59 $497,156 - $580,648
126,503 Added 182.57%
195,793 $836,000
Q2 2024

Aug 14, 2024
SELL
$4.2 - $6.18 $113,219 - $166,594
-26,957 Reduced 28.01%
69,290 $295,000
Q1 2024

May 15, 2024
SELL
$6.08 - $8.28 $215,353 - $293,277
-35,420 Reduced 26.9%
96,247 $591,000
Q4 2023

Feb 15, 2024
BUY
$5.13 - $8.35 $110,690 - $180,167
21,577 Added 19.6%
131,667 $1.08 Million
Q3 2023

Nov 07, 2023
BUY
$4.4 - $6.91 $153,942 - $241,760
34,987 Added 46.59%
110,090 $653,000
Q2 2023

Aug 03, 2023
BUY
$4.88 - $7.39 $100,235 - $151,790
20,540 Added 37.64%
75,103 $376,000
Q1 2023

May 04, 2023
SELL
$4.66 - $6.52 $13,947 - $19,514
-2,993 Reduced 5.2%
54,563 $330,000
Q4 2022

Feb 13, 2023
BUY
$3.7 - $5.29 $110,959 - $158,641
29,989 Added 108.79%
57,556 $277,000
Q3 2022

Nov 03, 2022
BUY
$2.72 - $4.61 $13,529 - $22,930
4,974 Added 22.02%
27,567 $105,000
Q2 2022

Aug 12, 2022
SELL
$2.71 - $7.12 $95,161 - $250,018
-35,115 Reduced 60.85%
22,593 $61,000
Q1 2022

May 16, 2022
SELL
$6.62 - $9.33 $236,770 - $333,696
-35,766 Reduced 38.26%
57,708 $391,000
Q4 2021

Feb 14, 2022
BUY
$8.3 - $11.29 $218,688 - $297,468
26,348 Added 39.25%
93,474 $813,000
Q3 2021

Nov 09, 2021
BUY
$9.73 - $13.38 $193,879 - $266,609
19,926 Added 42.22%
67,126 $759,000
Q2 2021

Aug 13, 2021
SELL
$9.02 - $11.68 $436,468 - $565,183
-48,389 Reduced 50.62%
47,200 $478,000
Q1 2021

May 13, 2021
SELL
$9.53 - $15.42 $369,802 - $598,357
-38,804 Reduced 28.87%
95,589 $1.12 Million
Q4 2020

Feb 11, 2021
SELL
$10.35 - $15.94 $141,318 - $217,644
-13,654 Reduced 9.22%
134,393 $1.42 Million
Q3 2020

Nov 12, 2020
BUY
$10.24 - $19.58 $398,796 - $762,543
38,945 Added 35.7%
148,047 $1.8 Million
Q2 2020

Aug 12, 2020
SELL
$9.71 - $17.87 $90,497 - $166,548
-9,320 Reduced 7.87%
109,102 $1.27 Million
Q1 2020

May 13, 2020
SELL
$5.57 - $10.76 $20,402 - $39,413
-3,663 Reduced 3.0%
118,422 $1.27 Million
Q4 2019

Feb 10, 2020
BUY
$7.21 - $8.89 $221,123 - $272,647
30,669 Added 33.55%
122,085 $980,000
Q3 2019

Nov 14, 2019
BUY
$6.57 - $9.46 $57,106 - $82,226
8,692 Added 10.51%
91,416 $684,000
Q2 2019

Aug 14, 2019
SELL
$8.17 - $11.07 $224,536 - $304,236
-27,483 Reduced 24.94%
82,724 $768,000
Q1 2019

May 15, 2019
BUY
$9.63 - $13.09 $713,602 - $969,995
74,102 Added 205.24%
110,207 $1.23 Million
Q4 2018

Feb 14, 2019
SELL
$10.53 - $15.54 $724,895 - $1.07 Million
-68,841 Reduced 65.6%
36,105 $422,000
Q3 2018

Nov 14, 2018
BUY
$15.25 - $17.72 $1.22 Million - $1.41 Million
79,682 Added 315.4%
104,946 $1.62 Million
Q2 2018

Aug 14, 2018
SELL
$14.46 - $18.08 $184,365 - $230,519
-12,750 Reduced 33.54%
25,264 $416,000
Q1 2018

May 15, 2018
BUY
$16.77 - $22.04 $371,807 - $488,648
22,171 Added 139.94%
38,014 $641,000
Q4 2017

Feb 14, 2018
SELL
$13.44 - $22.81 $382,112 - $648,511
-28,431 Reduced 64.22%
15,843 $299,000
Q3 2017

Nov 14, 2017
BUY
$19.97 - $22.74 $884,151 - $1.01 Million
44,274
44,274 $996,000

Others Institutions Holding OSUR

# of Institutions
201
Shares Held
65.4M
Call Options Held
2.2K
Put Options Held
5.1K
View Full List

About ORASURE TECHNOLOGIES INC

OSUR Quotes by TradingView
  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $264M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email